Peg Davis

4.2k total citations
121 papers, 3.4k citations indexed

About

Peg Davis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Peg Davis has authored 121 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 108 papers in Cellular and Molecular Neuroscience and 15 papers in Physiology. Recurrent topics in Peg Davis's work include Neuropeptides and Animal Physiology (107 papers), Receptor Mechanisms and Signaling (63 papers) and Chemical Synthesis and Analysis (56 papers). Peg Davis is often cited by papers focused on Neuropeptides and Animal Physiology (107 papers), Receptor Mechanisms and Signaling (63 papers) and Chemical Synthesis and Analysis (56 papers). Peg Davis collaborates with scholars based in United States, Italy and Poland. Peg Davis's co-authors include Frank Porreca, Victor J. Hruby, Henry I. Yamamura, Edward J. Bilsky, Josephine Lai, Shou-wu Ma, Richard B. Rothman, Todd W. Vanderah, Silvia N. Calderon and Kenner C. Rice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Gastroenterology.

In The Last Decade

Peg Davis

120 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peg Davis United States 34 2.7k 2.2k 631 587 205 121 3.4k
David C. Horwell United Kingdom 30 1.7k 0.6× 1.3k 0.6× 344 0.5× 933 1.6× 247 1.2× 110 2.8k
Gianfranco Balboni Italy 35 2.2k 0.8× 1.6k 0.8× 565 0.9× 781 1.3× 197 1.0× 163 3.6k
Stephen M. Husbands United Kingdom 33 2.7k 1.0× 2.5k 1.2× 720 1.1× 419 0.7× 70 0.3× 157 4.0k
Géza Tóth Hungary 35 2.8k 1.1× 2.6k 1.2× 789 1.3× 366 0.6× 270 1.3× 244 4.2k
Nga N. Chung Canada 27 2.3k 0.9× 1.9k 0.9× 349 0.6× 417 0.7× 127 0.6× 102 2.7k
Mari R. Candelore United States 28 3.1k 1.2× 1.8k 0.8× 700 1.1× 390 0.7× 93 0.5× 47 4.2k
Lawrence H. Lazarus United States 31 2.2k 0.8× 2.1k 1.0× 414 0.7× 239 0.4× 75 0.4× 102 2.9k
Raymond S.L. Chang United States 31 2.7k 1.0× 1.6k 0.7× 242 0.4× 1.6k 2.8× 277 1.4× 114 4.7k
Helmut Schmidhammer Austria 30 1.4k 0.5× 1.5k 0.7× 666 1.1× 452 0.8× 84 0.4× 143 2.4k
H. Timmerman Netherlands 26 1.5k 0.6× 477 0.2× 515 0.8× 614 1.0× 167 0.8× 91 3.1k

Countries citing papers authored by Peg Davis

Since Specialization
Citations

This map shows the geographic impact of Peg Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peg Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peg Davis more than expected).

Fields of papers citing papers by Peg Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peg Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peg Davis. The network helps show where Peg Davis may publish in the future.

Co-authorship network of co-authors of Peg Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Peg Davis. A scholar is included among the top collaborators of Peg Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peg Davis. Peg Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Peg, et al.. (2015). Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors. Bioorganic & Medicinal Chemistry Letters. 25(19). 4148–4152. 5 indexed citations
2.
Mollica, Adriano, Alfonso Carotenuto, Ettore Novellino, et al.. (2014). Novel Cyclic Biphalin Analogue with Improved Antinociceptive Properties. ACS Medicinal Chemistry Letters. 5(9). 1032–1036. 32 indexed citations
3.
Largent‐Milnes, Tally M., Denise Giuvelis, Takashi Yamamoto, et al.. (2013). Building a Better Analgesic: Multifunctional Compounds that Address Injury-Induced Pathology to Enhance Analgesic Efficacy while Eliminating Unwanted Side Effects. Journal of Pharmacology and Experimental Therapeutics. 347(1). 7–19. 27 indexed citations
4.
Okun, Alec, Ping Liu, Peg Davis, et al.. (2012). Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain. 153(4). 924–933. 108 indexed citations
5.
Vardanyan, Ruben, Vlad K. Kumirov, Gary S. Nichol, et al.. (2011). Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. Bioorganic & Medicinal Chemistry. 19(20). 6135–6142. 22 indexed citations
6.
Mollica, Adriano, Francesco Pinnen, Federica Feliciani, et al.. (2010). New potent biphalin analogues containing p-fluoro-l-phenylalanine at the 4,4′ positions and non-hydrazine linkers. Amino Acids. 40(5). 1503–1511. 29 indexed citations
7.
Giordano, Cesare, Anna Sansone, Annalisa Masi, et al.. (2010). Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2. European Journal of Medicinal Chemistry. 45(10). 4594–4600. 26 indexed citations
8.
Hruby, Victor J., Frank Porreca, Henry I. Yamamura, et al.. (2006). New paradigms and tools in drug design for pain and addiction. The AAPS Journal. 8(3). E450–E460. 21 indexed citations
9.
Mollica, Adriano, Peg Davis, Shou-wu Ma, et al.. (2005). Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkers. Bioorganic & Medicinal Chemistry Letters. 15(10). 2471–2475. 25 indexed citations
10.
Gu, Xuyuan, Jinfa Ying, Peg Davis, et al.. (2005). Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]‐Leu‐enkephalin analogues. Biopolymers. 80(2-3). 151–163. 12 indexed citations
11.
Mollica, Adriano, Peg Davis, Shou-wu Ma, et al.. (2005). Synthesis and biological activity of the first cyclic biphalin analogues. Bioorganic & Medicinal Chemistry Letters. 16(2). 367–372. 35 indexed citations
12.
Lipkowski, Andrzej W., Aleksandra Misicka, Peg Davis, et al.. (1999). Biological activity of fragments and analogues of the potent dimeric opioid peptide, biphalin. Bioorganic & Medicinal Chemistry Letters. 9(18). 2763–2766. 37 indexed citations
13.
Li, Guigen, W. Haq, Bih‐Show Lou, et al.. (1998). Modifications of the 4,4′-residues and sar studies of biphalin, a highly potent opioid receptor active peptide. Bioorganic & Medicinal Chemistry Letters. 8(5). 555–560. 24 indexed citations
14.
Davis, Peg, et al.. (1997). Opioid Peptides: Simultaneous δ Agonism and μ Antagonism in Somatostatin Analogues. Peptides. 18(1). 93–100. 13 indexed citations
15.
Bertha, Craig M., JUDITH L. FLIPPEN‐ANDERSON, Richard B. Rothman, et al.. (1995). Probes for Narcotic Receptor-Mediated Phenomena. 20. Alteration of Opioid Receptor Subtype Selectivity of the 5-(3-Hydroxyphenyl)morphans by Application of the Message-Address Concept: Preparation of .delta.-Opioid Receptor Ligands. Journal of Medicinal Chemistry. 38(9). 1523–1537. 8 indexed citations
16.
Qian, Xinhua, Mark D. Shenderovich, Bih‐Show Lou, et al.. (1994). Newly discovered stereochemical requirements in the side-chain conformation of .delta. opioid agonists for recognizing opioid .delta. receptors. Journal of Medicinal Chemistry. 37(12). 1746–1757. 49 indexed citations
17.
Davis, Peg, Teresa Zalewska, Jiřina Slaninová, et al.. (1994). Cyclic enkephalin analogs with exceptional potency at peripheral .delta. opioid receptors. Journal of Medicinal Chemistry. 37(1). 146–150. 17 indexed citations
18.
Davis, Thomas P., Terrence J. Gillespie, Jennifer E. Shook, et al.. (1991). Changes in opioid receptor selectivity following processing of peptide E: Effect on gut motility. Gastroenterology. 100(6). 1603–1615. 5 indexed citations
19.
Kramer, Thomas H., Géza Tóth, Ronald C. Haaseth, et al.. (1991). Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro. Life Sciences. 48(9). 881–886. 8 indexed citations
20.
Tóth, Géza, Thomas H. Kramer, Richard J. Knapp, et al.. (1990). [Cyclic] [D-Pen2,D-Pen5]enkephalin analogs with increased affinity and selectivity for .delta.-opioid receptors. Journal of Medicinal Chemistry. 33(1). 249–253. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. Horwell Breakdown of academic impact, for papers by Gianfranco Balboni Breakdown of academic impact, for papers by Stephen M. Husbands Breakdown of academic impact, for papers by Géza Tóth Breakdown of academic impact, for papers by Nga N. Chung Breakdown of academic impact, for papers by Mari R. Candelore Breakdown of academic impact, for papers by Lawrence H. Lazarus Breakdown of academic impact, for papers by Raymond S.L. Chang Breakdown of academic impact, for papers by Helmut Schmidhammer Breakdown of academic impact, for papers by H. Timmerman
Rankless by CCL
2026